Vijay Chiruvolu, PhD, MBA, is the Chief Technical Officer for Instil Bio responsible for Process Development, Quality, Manufacturing, Supply Chain and Facilities & Engineering. Vijay has extensive technical leadership experience in development and manufacturing of recombinant proteins, monoclonal antibodies, gene and cell therapy products.
Most recently, Dr. Chiruvolu was Senior Vice President of Process Development at Kite, a Gilead Company since joining in 2014. During his time at Kite, Dr. Chiruvolu was responsible for the CMC/process development that led to approval of two cell therapy products, Yescarta® and Tecartus®.
Prior to joining Kite, Dr. Chiruvolu has spent 18 years in various positions in Process Development, Manufacturing, and Quality with increasing leadership responsibilities at Scios, Avigen, Hoffmann-La Roche, Johnson & Johnson and Amgen. Vijay serves on biotech advisory board of PDA and leads PDA’s process validation and cell & gene therapy interest groups.
Vijay holds a PhD (Biochem. Eng.) from University of Nebraska-Lincoln and an MBA in finance and strategy from Penn State’s Smeal College of Business.